Form 4: Humana Chief Legal Officer Reports Stock Transactions

Humana's Chief Legal Officer, Joseph C. Ventura, reported the acquisition and disposition of common stock and the exercise of restricted stock units on December 15, 2025.

Summary

• Joseph C. Ventura, Humana Inc.'s Chief Legal Officer, reported transactions involving Humana Common Stock on December 15, 2025.
• Acquired 2,046 shares of Humana Common Stock through a deemed exercise or vesting event at a price of $0.
• Disposed of 933 shares of Humana Common Stock at a price of $270.155 to cover tax liabilities.
• Acquired an additional 360 shares of Humana Common Stock through a deemed exercise or vesting event at a price of $0.
• Disposed of 164 shares of Humana Common Stock at a price of $270.155 to cover tax liabilities.
• Following these transactions, Joseph C. Ventura directly beneficially owns 16,530 shares of Humana Common Stock.
• Indirectly beneficially owns 290 shares held for his benefit under the Humana Retirement Savings Plan as of November 30, 2025.
• Holds various stock options with exercise prices ranging from $350.7875 to $510.2425 and expiration dates between February 24, 2027, and February 21, 2031.
• The transactions related to restricted stock units granted on February 24, 2023, with 33% vesting on December 15, 2025.

Sentiment

Score: 6

Explanation: The transactions are routine for executive compensation, involving the vesting of restricted stock units and subsequent share sales to cover tax obligations. While the net effect is a slight reduction in direct holdings due to tax sales, the underlying vesting indicates continued executive incentive alignment and retention, which is a neutral to slightly positive signal.

Positives

• The acquisition of 2,406 shares (2,046 + 360) through vesting or exercise indicates continued participation in the company's equity incentive plans.
• Ongoing vesting of restricted stock units and stock options aligns executive interests with shareholder value over the long term.

Negatives

• Disposition of 1,097 shares (933 + 164) to cover tax liabilities resulted in a reduction of direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Executive compensation transactions involving the grant and vesting of equity awards (stock options and restricted stock units) under the company's 2019 Amended & Restated Stock Incentive Plan.

Stakeholder Impact

• Shareholders: These routine transactions reflect standard executive compensation practices and do not indicate a material change in company strategy or performance. They demonstrate ongoing executive alignment with shareholder interests through equity ownership.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• Future vesting of remaining stock options granted between 2020 and 2024, with the latest vesting extending to February 21, 2027.

Key Dates

Recommendation

The filing details routine executive compensation transactions, including the vesting of restricted stock units and subsequent share dispositions for tax purposes. These are standard occurrences and do not indicate a change in the company's fundamental performance or outlook, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Humana, HUM, Insider Trading, Form 4, Executive Compensation, Stock Options, Restricted Stock Units, Joseph C. Ventura